In this issue:
Optic neuritis diagnostic criteria
Suggested revisions to RIS diagnostic criteria
Cladribine tablets vs. other oral DMTs
Teriflunomide & EBV shedding in RRMS
Neural stem cell transplantation in progressive MS
Dimethyl fumarate in RIS to delay MS
sGFAP vs. sNfL as biomarkers for progression
Pathogenic distinctions of PPMS, SPMS & RRMS
Discontinuation of DMTs in patients ≥55 years
Discontinuation of DMTs in patients >60 years
Please login below to download this issue (PDF)